Johnathan Engh, MDAssociate Professor of Neurological Surgery
Director, Neuroendoport Surgery Program
Director, Adult Neurosurgical Oncology
Johnathan Engh, MD, joined the faculty at the University of Pittsburgh Department of Neurological Surgery in 2008 after completing the department’s seven-year residency program. Originally from northern Virginia, Dr. Engh is a graduate of Duke University and the University of Virginia Medical School.
Dr. Engh’s clinical focus is on neurosurgical oncology, especially minimally invasive operations for central nervous system tumors and intraventricular lesions. He is the director of the adult neurosurgical oncology program at the University of Pittsburgh. From a research perspective, his major interests are the development of minimally invasive tools for cranial surgery and percutaneous intracerebral navigation.
Dr. Engh's publications can be reviewed through the National Library of Medicine's publication database.
See also: Dr. Engh Receives ACES Award
Specialized Areas of Interest
CNS tumors, minimally invasive surgery, neurosurgical technology and innovation.
American Board of Neurological Surgery
Children’s Hospital of Pittsburgh of UPMC
Magee-Womens Hospital of UPMC
Professional Organization Membership
Allegheny County Medical Society
Alpha Omega Alpha
American Association of Neurological Surgeons
Congress of Neurological Surgeons
PA Medical Society
Society of Neuro-Oncology
University of Pittsburgh Cancer Institute
UPMC OnTopic Videos
Neuroendoport® for Brain Tumors
Dr. Engh discusses the benefits of Neuroendoport® surgery to remove brain tumors
19-year-old cyst patient
August 17, 2012
Pitt RB hospitalized: Derrick Burns in stable condition
May 24, 2012
Young Stroke Victims
May 11, 2012
WTAE-TV Action News
Surgery through a straw
February 19, 2009
Johnathan Engh, MD, and his research partner, Gregg Podnar, designed a prototype dilatable endoscopic port for brain surgery which is the subject of a patent published by the University of Pittsburgh on August 1, 2013 (US 2013/0197316 A1). The first prototype of this device was recently constructed.
Established research projects include analysis of stem cell markers in glioma specimens and molecular differentiation of central nervous system metastases from solid organ metastases. A comprehensive revamped neurosurgical tissue banking program has been established under his leadership, which has led to new collaborations among neurosurgeons and researchers at the Hillman Cancer Center.
Additional research projects include study of the application of minimally invasive navigational techniques (flexible needle steering) within the white matter of the brain. This project is in collaboration with Cameron Riviere, PhD, of Carnegie Mellon University. Animal safety testing trials of the needle-steering device in a pig model were completed in the Copeland laboratories of the University of Pittsburgh in spring of 2014.
Dr. Engh is a co-investigator on multiple clinical trials for brain tumor patients through the Hillman Cancer Center.